Finasteride

Educational summary, not a formulary. Dosing is quoted from the Makindo chapters and topics site. The other sections are draft summaries not yet checked line by line against the BNF or SPC. Check dose, indication, interactions and monitoring in the BNF entry for Finasteride and local guidelines before prescribing.

5-alpha reductase inhibitor

Mechanism

5-alpha reductase type 2 inhibitor reducing dihydrotestosterone.

Uses

Benign prostatic hyperplasia, male-pattern hair loss.

Dosing

Side effects

Reduced libido, erectile dysfunction, ejaculatory problems, gynaecomastia; mood changes.

Interactions

Few clinically important interactions.

Contraindications and cautions

Women of childbearing potential (handling), hypersensitivity

Monitoring

PSA at baseline, breast symptoms

Pregnancy and breastfeeding

Contraindicated

Renal and hepatic impairment

Caution in severe liver impairment

Overdose and reversal

Supportive

Special advice

PSA falls by about half after 6 months; do not handle crushed tablets in pregnancy; breast changes need review.

More from the textbook: uses, cautions and other points
Where it is discussed in the book